In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with ...

The FDA pulls back another treatment that doesn't work against omicron, and the federal government warns that without more funding it'll run out of antibodies to give states. Jessica was a writer on ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

The FDA has granted breakthrough therapy designation to INCA033989 for some patients with essential thrombocythemia.

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

B cells play a vital role in the immune system, given their key function in antibody production. Antibodies, also known as immunoglobulins, are glycosylated protein molecules that appear on the ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Monoclonal antibody treatments have given new hope for those fighting COVID-19, and they've been intensely politicized as well. Millions in the South, for example, rejected vaccination in favor of ...

A new artificial intelligence model could help design antibodies that better protect the body against viruses and disease.

A newly engineered antibody can penetrate kidney cysts and interrupt the growth signals that drive polycystic kidney disease.

Elanco's monoclonal antibody therapy, Trutect, received a conditional license from the federal agency in 2023.